Details of the Drug

General Information of Drug (ID: DMP9N85)

Drug Name

Menadiol sodium diphosphate

Synonyms

Kappadione; Synkavit; Procoagulo; Synkavite; Thylokay; Kipca water soluble; Synkayvite; Menadiol sodium diphosphate; Menadione sodium phosphate; Sodium menadione diphosphate; Menadiol Sodium Diphosphate Anhydrous; UNII-R2L46WE615; Menadiol tetrasodium diphosphate; EINECS 205-012-1; Menadione diphosphate tetrasodium salt; 1:4-Naphthaquinol-bisdisodium phosphate; 131-13-5; Menadiol sodium diphosphate anhydrous [USAN]; R2L46WE615; 2-Methyl-1,4-naphthaquinol bis(disodium phosphate); Tetrasodium 2-methyl-1,4-naphthalenediol diphosp

Indication

Disease Entry	ICD 11	Status	REF
Coagulation defect	3B10.0	Approved	[1]
Obstructive jaundice	N.A.	Approved	[2]

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

#Ro5 Violations (Lipinski):
0

Molecular Weight

422.08

Logarithm of the Partition Coefficient

Not Available

Rotatable Bond Count

Hydrogen Bond Donor Count

Hydrogen Bond Acceptor Count

ADMET Property

Clearance: The clearance of drug is 0.822 +/- 0.254 L/min []
Elimination: In tracer studies, it was found that approximately 20% of an injected dose of phylloquinone (Vitamin K metabolite) was found in the urine whereas about 40-50 % was excreted in the feces via the biliary system [3]
Half-life: The concentration or amount of drug in body reduced by one-half in 27.17 minutes [4]
Metabolism: The drug is metabolized via the enzymes such as microsomal NADPHCcytochrome P450 reductase and mitochondrial NADHCubiquinone oxidoreductase (complex I) [5]
Vd: The volume of distribution (Vd) of drug is 30.833 +/- 12.835 L [6]

Chemical Identifiers

Formula: C11H8Na4O8P2
IUPAC Name: tetrasodium;(2-methyl-4-phosphonatooxynaphthalen-1-yl) phosphate
Canonical SMILES: CC1=C(C2=CC=CC=C2C(=C1)OP(=O)([O-])[O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+]
InChI: InChI=1S/C11H12O8P2.4Na/c1-7-6-10(18-20(12,13)14)8-4-2-3-5-9(8)11(7)19-21(15,16)17;;;;/h2-6H,1H3,(H2,12,13,14)(H2,15,16,17);;;;/q;4*+1/p-4
InChIKey: GZBACHSOZNEZOG-UHFFFAOYSA-J

Cross-matching ID

PubChem CID: 8555
CAS Number: 131-13-5
UNII: R2L46WE615
DrugBank ID: DB09332
TTD ID: D09KGQ
INTEDE ID: DR0902

Drug ADMET Endpoint Profile (DAE)^NEW

Click to Jump to the Detailed DAE Information of This Drug

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug

Drug-Metabolizing Enzyme (DME)

DME Name	DME ID	UniProt ID	MOA	REF
NADPH-cytochrome P450 reductase (CPR)	DE3N2FM	NCPR_HUMAN	Substrate	[7]
Vitamin K1 2,3-epoxide reductase 1 (VKOR)	DEVRYQN	VKOR1_HUMAN	Substrate	[8]

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2	Menadiol sodium diphosphate FDA Label
3	Chapter 10. Vitamin K
4	Menadione
5	Madelain V, Nguyen TH, Olivo A, de Lamballerie X, Guedj J, Taburet AM, Mentre F: Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials. Clin Pharmacokinet. 2016 Aug;55(8):907-23. doi: 10.1007/s40262-015-0364-1.
6	A pharmacokinetic study with the high-dose anticancer agent menadione in rabbits
7	Creatinine sulfate/esculoside/hesperidin methyl chalcone/menadiol sodium phosphate/tranexamic acid actions.
8	SMPDB database: Vitamin K Metabolism